Literature DB >> 17914168

From nutraceuticals to pharmaceuticals to nanopharmaceuticals: a case study in angiogenesis modulation during oxidative stress.

Shaker A Mousa1, Dhruba J Bharali, Donald Armstrong.   

Abstract

This report reviews the potential applications of nanotechnology in various therapeutics and diagnostics areas with special emphasis on key frontiers in angiogenesis modulation using naturally driven drug targets including compounds that modulate oxidative stress and inflammatory pathways for the potential treatment of vascular, cancer, inflammatory, and ocular disorders. Recent advances of the nanotechnology mediated gene delivery are also described in this paper.

Entities:  

Mesh：

Year:  2007        PMID： 17914168     DOI： 10.1007/s12033-007-0064-7

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN： 1073-6085            Impact factor:   2.695


  50 in total

Review 1.  Clinical applications of angiogenic growth factors and their inhibitors.

Authors:  N Ferrara; K Alitalo
Journal:  Nat Med       Date:  1999-12       Impact factor: 53.440

Review 2.  Nanomedicines for overcoming biological barriers.

Authors:  Maria José Alonso
Journal:  Biomed Pharmacother       Date:  2004-04       Impact factor: 6.529

3.  Inorganic-organic hybrid nanoparticles from n-octyl triethoxy silane.

Authors:  Shraboni Das; Tapan Kumar Jain; Amarnath Maitra
Journal:  J Colloid Interface Sci       Date:  2002-08-01       Impact factor: 8.128

Review 4.  Nanomedicine: clinical applications of polyethylene glycol conjugated proteins and drugs.

Authors:  Suphiya Parveen; Sanjeeb K Sahoo
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

5.  Quantum dot bioconjugates for ultrasensitive nonisotopic detection.

Authors:  W C Chan; S Nie
Journal:  Science       Date:  1998-09-25       Impact factor: 47.728

6.  Calcium phosphate nanoparticles as novel non-viral vectors for targeted gene delivery.

Authors:  Indrajit Roy; Susmita Mitra; Amarnath Maitra; Subho Mozumdar
Journal:  Int J Pharm       Date:  2003-01-02       Impact factor: 5.875

7.  Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis.

Authors:  M Streit; L Riccardi; P Velasco; L F Brown; T Hawighorst; P Bornstein; M Detmar
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

Review 8.  The molecular genetics of cancer.

Authors:  J M Bishop
Journal:  Science       Date:  1987-01-16       Impact factor: 47.728

9.  Lipid hydroperoxide-induced tumor necrosis factor (TNF)-alpha, vascular endothelial growth factor and neovascularization in the rabbit cornea: effect of TNF inhibition.

Authors:  Toshihiko Ueda; Takako Ueda; Shohei Fukuda; Richard Browne; Edwin Jenis; Robert Spengler; Richard Chou; Peter Buch; Ahmad Aljada; Paresh Dandona; R. Sasisekharan; C. Kathleen Dorey; Donald Armstrong
Journal:  Angiogenesis       Date:  1998       Impact factor: 9.596

10.  Treatment of human pancreatic cancer in mice with angiogenic inhibitors.

Authors:  Daniela Prox; Christian Becker; Steven R Pirie-Shepherd; Ilhan Celik; Judah Folkman; Oliver Kisker
Journal:  World J Surg       Date:  2003-04       Impact factor: 3.352
View more
  3 in total

Review 1.  Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer.

Authors:  Hareesh B Nair; Bokyung Sung; Vivek R Yadav; Ramaswamy Kannappan; Madan M Chaturvedi; Bharat B Aggarwal
Journal:  Biochem Pharmacol       Date:  2010-07-21       Impact factor: 5.858

2.  Micronutrients attenuate progression of prostate cancer by elevating the endogenous inhibitor of angiogenesis, platelet factor-4.

Authors:  David Cervi; Brian Pak; Natalie A Venier; Linda M Sugar; Robert K Nam; Neil E Fleshner; Laurence H Klotz; Vasundara Venkateswaran
Journal:  BMC Cancer       Date:  2010-06-04       Impact factor: 4.430

Review 3.  Nanotechnology: A Revolution in Cancer Diagnosis.

Authors:  V Jaishree; P D Gupta
Journal:  Indian J Clin Biochem       Date:  2012-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.